Testing effectiveness (Phase 2)Study completedNCT00012337What this trial is testingZD 1839 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Memorial Sloan Kettering Cancer Center
Very early researchStudy completedNCT03473730What this trial is testingDaratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney CancerWho this might be right forBladder Urothelial CarcinomaClear Cell Renal Cell CarcinomaMalignant Urinary System Neoplasm+2 more M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)UnknownNCT00024388What this trial is testingChemotherapy in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Theradex
Testing effectiveness (Phase 2)Study completedNCT00003968What this trial is testingBryostatin 1 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT02166255What this trial is testingAPN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more Wake Forest University Health Sciences 17
Very early researchActive Not RecruitingNCT02210117What this trial is testingNivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by SurgeryWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage IV Renal Cell Cancer AJCC v7 M.D. Anderson Cancer Center 104
Testing effectiveness (Phase 2)Study completedNCT00057889What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell CancerWho this might be right forKidney Cancer National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT01158534What this trial is testingCelecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone SurgeryWho this might be right forRenal Cell CancerStage IV Renal Cell Cancer Case Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)WithdrawnNCT00040989What this trial is testingBAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney CancerWho this might be right forStage IV Renal Cell CancerRecurrent Renal Cell Cancer Jonsson Comprehensive Cancer Center
Early research (Phase 1)WithdrawnNCT00006126What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With SurgeryWho this might be right forBreast CancerKidney CancerLung Cancer+2 more Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00027573What this trial is testingChemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forKidney Cancer Alliance for Clinical Trials in Oncology 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT03541902What this trial is testingCabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell CarcinomaWho this might be right forMalignant Neoplasms of Urinary TractRenal Cell CarcinomaChromophobe Renal Cell Carcinoma+6 more M.D. Anderson Cancer Center 32
Early research (Phase 1)Ended earlyNCT01943188What this trial is testingStereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer Stanford University 2
Not applicableEnded earlyNCT01740154What this trial is testingSunitinib Malate Related Fatigue in Patients With Metastatic Kidney CancerWho this might be right forFatigueRecurrent Renal Cell CancerStage IV Renal Cell Cancer Case Comprehensive Cancer Center 13
Not applicableStudy completedNCT00005799What this trial is testingFludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07218692What this trial is testingRP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on ImmunotherapyWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+6 more City of Hope Medical Center 35
Early research (Phase 1)Ended earlyNCT02419495What this trial is testingPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)Study completedNCT00278395What this trial is testingVorinostat in Treating Patients With Kidney CancerWho this might be right forRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT00814021What this trial is testingSunitinib in Treating Patients With Kidney Cancer That Has Spread to the BrainWho this might be right forKidney CancerMetastatic Cancer Institut Claudius Regaud 21
Not applicableStudy completedNCT00806650What this trial is testingAnti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney CancerWho this might be right forKidney Cancer City of Hope Medical Center 155